Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Ana Isabel Padrão"'
Autor:
Ana Reis-Mendes, Ana Isabel Padrão, José Alberto Duarte, Salomé Gonçalves-Monteiro, Margarida Duarte-Araújo, Fernando Remião, Félix Carvalho, Emília Sousa, Maria Lourdes Bastos, Vera Marisa Costa
Publikováno v:
Biomolecules, Vol 11, Iss 11, p 1725 (2021)
Doxorubicin (DOX) is a topoisomerase II inhibitor commonly used in the treatment of several types of cancer. Despite its efficacy, DOX can potentially cause fatal adverse effects, like cardiotoxicity. This work aimed to assess the role of inflammatio
Externí odkaz:
https://doaj.org/article/ec9e2f7caa8e4a5d832370426ace8b2f
Autor:
Ana Reis-Mendes, José Luís Dores-Sousa, Ana Isabel Padrão, Margarida Duarte-Araújo, José Alberto Duarte, Vítor Seabra, Salomé Gonçalves-Monteiro, Fernando Remião, Félix Carvalho, Emília Sousa, Maria Lourdes Bastos, Vera Marisa Costa
Publikováno v:
Pharmaceuticals, Vol 14, Iss 6, p 510 (2021)
Mitoxantrone (MTX) is a pharmaceutical drug used in the treatment of several cancers and refractory multiple sclerosis (MS). Despite its therapeutic value, adverse effects may be severe, namely the frequently reported cardiotoxicity, whose mechanisms
Externí odkaz:
https://doaj.org/article/dcd80e51595a4a5ba63be05dcd0c6c2c
Autor:
Julien, Louis, Sam, Bennett, Daniel J, Owens, Eve, Tiollier, Franck, Brocherie, Marcelo A. S., Carneiro, Paulo Ricardo P., Nunes, Bruna, Costa, Pâmela, Castro-e-Souza, Luís A., Lima, Felipe, Lisboa, Gersiel, Oliveira-Júnior, Witalo, Kassiano, Edilson S., Cyrino, Fábio L., Orsatti, Arthur Henrique, Bossi, Guilherme, Matta, Géssyca, Tolomeu de Oliveira, Ferreira, Renato Melo, Everton, Rocha Soares, Bruno, Ocelli Ungheri, Matheus, Daros Pinto, James L., Nuzzo, Christopher, Latella, Daniel, van den Hoek, Alistair, Mallard, Jemima, Spathis, Justin A., DeBlauw, Stephen J., Ives, Nicholas, Ravanelli, Benjamin J., Narang, Tadej, Debevec, Liliana C., Baptista, Ana Isabel, Padrão, José, Oliveira, Jorge, Mota, Rodrigo, Zacca, Pantelis T., Nikolaidis, Donovan J., Lott, Sean C., Forbes, Korey, Cooke, Tanja, Taivassalo, Steven J., Elmer, John J., Durocher, Ricardo J., Fernandes, Gonçalo, Silva, Mário J., Costa
Publikováno v:
Journal of applied physiology (Bethesda, Md. : 1985). 133(6)
Autor:
José Alberto Duarte, M.D.L. Bastos, E. Sousa, Ana Reis-Mendes, F. Carvalho, Vera Marisa Costa, Ana Isabel Padrão, Fernando Remião, Margarida Duarte-Araújo, S. Gonçalves-Monteiro
Publikováno v:
Toxicology Letters. 350:S132-S133
Autor:
Rita Ferreira, Ana Cristina Corrêa Figueira, José Alberto Duarte, Paula A. Oliveira, Carina Silva, Ana Isabel Padrão, Mafalda Corrêa Figueira
Publikováno v:
International Journal of Sports Medicine. 39:885-892
Despite the importance attributed to exercise training in the breast cancer (BC) continuum, the underlying mechanisms modulating tumor behavior are unknown. We evaluated the effects of long-term moderate-exercise in the development of mammary tumors,
Autor:
Félix Carvalho, Ana Isabel Padrão, Fernando Remião, Maria de Lourdes Bastos, Emília Sousa, Salomé Gonçalves-Monteiro, Margarida Duarte-Araújo, Vera Marisa Costa, Ana Reis-Mendes, José Alberto Duarte
Publikováno v:
Biomolecules, Vol 11, Iss 1725, p 1725 (2021)
Biomolecules; Volume 11; Issue 11; Pages: 1725
Biomolecules
Biomolecules; Volume 11; Issue 11; Pages: 1725
Biomolecules
Doxorubicin (DOX) is a topoisomerase II inhibitor commonly used in the treatment of several types of cancer. Despite its efficacy, DOX can potentially cause fatal adverse effects, like cardiotoxicity. This work aimed to assess the role of inflammatio
Autor:
Félix Carvalho, Ana Reis-Mendes, Emília Sousa, Maria de Lourdes Bastos, Fernando Remião, Vera Marisa Costa, José Luís Dores-Sousa, Margarida Duarte-Araújo, José Alberto Duarte, Vítor Seabra, Ana Isabel Padrão, Salomé Gonçalves-Monteiro
Publikováno v:
Pharmaceuticals, Vol 14, Iss 510, p 510 (2021)
Pharmaceuticals
Volume 14
Issue 6
Pharmaceuticals
Volume 14
Issue 6
Mitoxantrone (MTX) is a pharmaceutical drug used in the treatment of several cancers and refractory multiple sclerosis (MS). Despite its therapeutic value, adverse effects may be severe, namely the frequently reported cardiotoxicity, whose mechanisms
Autor:
Rita, Nogueira-Ferreira, Rita, Ferreira, Ana Isabel, Padrão, Paula, Oliveira, Manuel, Santos, Andreas N, Kavazis, Rui, Vitorino, Daniel, Moreira-Gonçalves
Publikováno v:
Journal of physiology and biochemistry. 75(4)
Aerobic exercise training induces a unique cardioprotective phenotype, but it is becoming clear that it does not promote the same structural, functional, and molecular adaptations in both ventricles. In the present study, we aimed to better character
Autor:
Adelino F. Leite-Moreira, Rita Ferreira, Francisco Amado, Sara Vieira, José Alberto Duarte, Tiago Henriques-Coelho, Cátia Santa, Hélder Fonseca, Daniel Moreira-Gonçalves, Ana Isabel Padrão, Ana Filipa Silva
Publikováno v:
The Journal of Physiology. 593:3885-3897
The present study aimed to test whether a chronic intermittent workload could induce an adaptive cardiac phenotype Chronic intermittent workload induced features of adaptive hypertrophy This was paralleled by protection against acute pressure overloa
Autor:
Paulo J. Oliveira, J. Ramon Torrella, Rita Ferreira, António Ascensão, Sílvia Rocha-Rodrigues, Estela Santos-Alves, José Magalhães, Diogo Mariani, Ana Isabel Padrão, Inês Marques-Aleixo, David Rizo-Roca, Ginés Viscor
Publikováno v:
Mitochondrion. 20:22-33
Doxorubicin (DOX) is an anti-cancer agent whose clinical usage results in a cumulative and dose-dependent cardiotoxicity. We have previously shown that exercise performed prior to DOX treatment reduces the resulting cardiac(mito) toxicity. We sought